Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-keto-L-gulonate decarboxylase (BKGD), also known as ester hydrolase C11orf54, is a highly conserved enzyme present in humans and other metazoans. It catalyzes the decarboxylation of β-keto-L-gulonate to L-xylulose, thus completing the pentose pathway and explaining the molecular origin of L-xylulose in human metabolism. This alternative route for pentose sugar conversion is evolutionarily ancient and offers a metabolic tradeoff relevant to ascorbate (vitamin C) biosynthesis. Structurally, BKGD features a zinc-coordinating motif and belongs to the metallo-β-lactamase fold protein superfamily. It also has weak in vitro ester hydrolase activity but is now primarily defined as a decarboxylase by recent studies. Beyond its metabolic role, BKGD/C11orf54 regulates cell proliferation, DNA damage response, and repair in mammalian cells, making it a biomarker for several cancers. The protein is cytoplasmic, with enrichment in kidney and liver, and interacts with various signaling and structural proteins relevant to cellular homeostasis. While direct pharmacological targeting is not yet established, modulation of its pathway (such as autophagy inhibitors) reveals therapeutic potential and safety concerns tied to genotoxic stress.
Bafilomycin A1 rescues C11orf54 knockdown-induced DNA damage by inhibiting chaperone-mediated autophagy, suggesting a functional, indirect mechanism via CMA inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-keto-L-gulonate decarboxylase (BKGD).